Evidence map›Paper›PMID 40855610›Full record

ArticleAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2025

Performance of Short-Term Culture and Direct MALDI-TOF MS for Identification of Candida Species From Blood Cultures.

Tugce Unalan-Altintop, Kristoffer Jansson, Volkan Özenci

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Performance of Short-Term Culture and Direct MALDI-TOF MS for Identification of Candida Species From Blood Cultures.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tugce Unalan-AltintopDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-5318-2942
Kristoffer JanssonDepartment of Clinical Microbiology, Karolinska University Hospitals, Stockholm, Sweden.
Volkan ÖzenciDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and reliable identification of Candida spp. is crucial due to changing epidemiology and increasing resistance. This study aims to compare the identification rates, average Log Score (LS) values, and three different methods: short-term culture, Sepsityper kit, and an in-house method. Simulated blood culture (BC) samples with clinical Candida isolates and human blood from healthy donors were used. Sepsityper kit was used according to manufacturers' recommendations. An in-house protocol was designed using SDS for lysis of erythrocytes. Short-term culture was performed by inoculation of BC broth on Sabouraud Dextrose Agar (SDA) and chromogenic plates and cultured for 6 h. A total of 52 clinical Candida isolates were included in the study. The identification rate was highest (71.9%) for the short-term culture method, 59.6% for the Sepsityper kit, and 57.3% for the in-house method when all types of bottles were analyzed. Higher identification rates were obtained using the BD BACTEC Mycosis-IC/F bottles: 76.7% for the short-term culture method, 100% for the in-house method, and 76.9% for the Sepsityper kit. Short-term culture has high performance in the identification of Candida species, despite a slightly longer detection time than direct MALDI-TOF MS methods.

Indexed as

Blood CultureCandidaCandidemiaCandidiasisSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansblood culturescandidemiaMALDI‐TOF MSSepsitypershort‐term culture

Identifiers

PMID40855610
PMCPMC12379042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.